In the journey to outperform the market, investors delve into the art of stock selection. Choosing the right stocks can be a powerful driver for wealth accumulation.
As of close of business last night, Pliant Therapeutics Inc’s stock clocked out at $11.00, up 0.73% from its previous closing price of $10.92. In other words, the price has increased by $0.73 from its previous closing price. On the day, 0.68 million shares were traded. PLRX stock price reached its highest trading level at $11.4 during the session, while it also had its lowest trading level at $10.85.
Ratios:
To gain a deeper understanding of PLRX’s stock, we examine its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 10.26 and its Current Ratio is at 10.26. In the meantime, Its Debt-to-Equity ratio is 0.17 whereas as Long-Term Debt/Eq ratio is at 0.17.
On December 08, 2023, Wells Fargo started tracking the stock assigning a Overweight rating and target price of $41.
On May 18, 2023, Canaccord Genuity started tracking the stock assigning a Buy rating and target price of $48.Canaccord Genuity initiated its Buy rating on May 18, 2023, with a $48 target price.
Insider Transactions:
Investing in insider trades can also provide an investor with insight into how management views future stock prices. A recent insider transaction in this stock occurred on Jan 17 ’25 when Coulie Bernard sold 52,419 shares for $11.20 per share. The transaction valued at 587,150 led to the insider holds 430,517 shares of the business.
Cummings Keith Lamont sold 20,148 shares of PLRX for $225,680 on Jan 17 ’25. The Chief Financial Officer now owns 262,608 shares after completing the transaction at $11.20 per share. On Jan 17 ’25, another insider, Hull Hans, who serves as the Chief Business Officer of the company, sold 15,936 shares for $11.20 each. As a result, the insider received 178,501 and left with 211,558 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, PLRX now has a Market Capitalization of 669389568 and an Enterprise Value of 320221568.
Stock Price History:
The Beta on a monthly basis for PLRX is 1.02, which has changed by -0.40877098 over the last 52 weeks, in comparison to a change of 0.23883796 over the same period for the S&P500. Over the past 52 weeks, PLRX has reached a high of $18.92, while it has fallen to a 52-week low of $10.22. The 50-Day Moving Average of the stock is -16.10%, while the 200-Day Moving Average is calculated to be -14.57%.
Shares Statistics:
It appears that PLRX traded 514.81K shares on average per day over the past three months and 539370 shares per day over the past ten days. A total of 60.85M shares are outstanding, with a floating share count of 53.87M. Insiders hold about 11.48% of the company’s shares, while institutions hold 96.27% stake in the company. Shares short for PLRX as of 1735603200 were 7167979 with a Short Ratio of 13.92, compared to 1732838400 on 7242084. Therefore, it implies a Short% of Shares Outstanding of 7167979 and a Short% of Float of 12.0299995.
